Intensification of myeloablative and reduced-intensity conditioning for patients with high-risk acute leukaemias with Y-90 labelled anti-CD66 antibody: results of a phase I-II study

BONE MARROW TRANSPLANTATION(2011)

引用 0|浏览15
暂无评分
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要